These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15551879

  • 1. [Effectiveness of treatments for hypertension in a sample of Colombian patients].
    Isaza CA, Moncada JC, Mesa G, Osorio FJ.
    Biomedica; 2004 Sep; 24(3):273-81. PubMed ID: 15551879
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O.
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 7. Medication reconciliation and hypertension control.
    Persell SD, Bailey SC, Tang J, Davis TC, Wolf MS.
    Am J Med; 2010 Feb; 123(2):182.e9-182.e15. PubMed ID: 20103029
    [Abstract] [Full Text] [Related]

  • 8. Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995.
    Wolf HK, Andreou P, Bata IR, Comeau DG, Gregor RD, Kephart G, MacLean DR, Sketris I.
    CMAJ; 1999 Sep 21; 161(6):699-704. PubMed ID: 10513276
    [Abstract] [Full Text] [Related]

  • 9. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb 21; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 10. Prehypertension and hypertension in a primary care practice.
    Godwin M, Pike A, Kirby A, Jewer C, Murphy L.
    Can Fam Physician; 2008 Oct 21; 54(10):1418-23. PubMed ID: 18854471
    [Abstract] [Full Text] [Related]

  • 11. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 21; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 12. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul 21; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 13. [Hypertension management in general practice in Iceland].
    Jensdóttir JO, Sigurethsson EL, Thornorgeirsson G.
    Laeknabladid; 2006 May 21; 92(5):375-80. PubMed ID: 16741320
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM.
    Rev Port Cardiol; 2009 May 21; 28(5):499-523. PubMed ID: 19650569
    [Abstract] [Full Text] [Related]

  • 15. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group.
    Am J Hypertens; 2006 Dec 21; 19(12):1217-25. PubMed ID: 17161766
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 21; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 17. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May 21; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q, Burt VL, Paulose-Ram R, Dillon CF.
    Am J Hypertens; 2008 Jul 21; 21(7):789-98. PubMed ID: 18451806
    [Abstract] [Full Text] [Related]

  • 19. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG.
    Circulation; 2009 Oct 20; 120(16):1598-605. PubMed ID: 19805653
    [Abstract] [Full Text] [Related]

  • 20. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 20; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.